TEM (Tempus) Operatsion marja

Tempus AI, Inc (TEM) brendining ramzi va logotipi

Onkologiya markazlari va dori vositalarini ishlab chiqishda AI texnologiyalaridan foydalanuvchi sog'liqni saqlash gigantlari bilan hamkorlik Tempus AI, Inc (TEM) kompaniyasining GURU.Markets vaqt grafiklarida ko'rsatilgan operatsion marjlar dinamikasini boshqaradi, bunda ko'rsatkich -17.50 darajasida turibdi. Strategik o'sish analitika sotuvi uchun genetik ma'lumotlarning kengaytiriladigan agregatsiyasiga asoslangan, biznes barqarorligi esa integratsiyalashgan biomateriallar yig'ish logistikasi va laboratoriya resurslari uchun diversifikatsiyalashgan ta'minot kanallari bilan kafolatlanadi.

tempus.com (TEM): Sotuvning operatsion marjasi 15.06.2024dan 19.11.2026gacha

Tempus Labs (TEM) kompaniyasining tahliliy kesimlari

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:tempus.com
Tempus AI Inc asosiy tovari

Operatsion marja asosiy biznes jarayonlaridan olingan foydaning umumiy daromadga nisbatan ulushini o'lchaydi va bu qarz majburiyatlari hamda soliqlarni hisobga olishdan oldin xarajatlarni boshqarish samaradorligini baholash imkonini beradi. Operatsion marja tendentsiyalarini tahlil qilish orqali investor Tempus AI, Inc (TEM) moliyaviy barqarorligini aniqlaydi, bunda sog'liqni saqlash gigantlari bilan tuzilgan shartnomalar orqali klinik ma'lumotlar to'plamlarining monetizatsiyasi ushbu yuqori texnologik biznes uchun daromadlarning oshishi bilan natijalanishi kerak.

Toʻgʻridan-toʻgʻri raqobatchilar

QGEN (Qiagen NV) - Operatsion marja|Sotuvning operatsion marjasi Ionis Pharma (IONS)|Operatsion rentabellik Repligen Corp (RGEN)|RNA - Sotuvning operatsion rentabelligi|crisprtx.com - Sotuvning operatsion marjasi|Operatsion foyda normasi WGS|RARE - Operatsion rentabellik|Beam Tx (BEAM) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik